BMS-986393 (CC-95266) Myeloma Trials

SparkCures ID	412
Developed By	Juno Therapeutics, a Subsidiary of Celgene
Generic Name	BMS-986393 (CC-95266)
Additional Names	CC-95266
Treatment Classifications	CAR T Cell

SparkCures ID

412

Developed By

Juno Therapeutics, a Subsidiary of Celgene

Generic Name

BMS-986393 (CC-95266)

Additional Names

CC-95266

Treatment Classifications

All Clinical Trials

View all active clinical trials around the US.

Verified

BMS-986393

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified

BMS-986393

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Smoldering Myeloma

No active clinical trials

Monoclonal Gammopathy of Undetermined Significance (MGUS)

No active clinical trials

BMS-986393 (CC-95266)